ESSA Pharma Inc.: cashflow_investing

Value{"amount": -4082539, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2024-10-01 – 2025-03-31
Statuscurrent
EntityESSA Pharma Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-25-006850 · Open the official SEC filing →
Retrieved: 2026-08-19T16:47:48.155835+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001633932/cashflow-investing/2025-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4c87dc92-609f-41fa-bab6-c5cd1a9ae5f6

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies